MAPT and pantothenate kinase-associated neurodegeneration: In MPAN patients, NfL, Tau, and UCH-L1 levels were significantly associated with disease severity, whereas in PKAN patients, Tau, GFAP, and UCH-L1 were the key correlating markers.